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Abstract 
Infection of cattle by bovine herpesvirus type 1 (BHV-1) can lead to upper respiratory tract 
disorders, conjunctivitis, genital disorders and immune suppression. BHV-1-induced immune 
suppression initiates bovine respiratory disease complex (BRDC), which costs the US cattle 
industry approximately 3 billion dollars annually. BHV-1 encodes at least three proteins that 
can inhibit specific arms of the irnmune system: (i) hICPO inhibits interferon-dependent 
t transcription, (ii) the UL41.5 protein inhibits C D ~ '  T-cell recognition of infected cells by 
preventing trafficking of viral peptides to the surface of the cells and (iii) glycoprotein G is a 
chemokine-binding protein that prevents homing of lymphocytes to sights of infection. 
Following acute infection of calves, BHV-1 can also infect and induce high levels of apoptosis 
t 
of CD4' T-cells. Consequently, the ability of BHV-1 to impair the immune response can lead to 
BRDC. Following acute infection, RHV-1 establishes latency in sensory neurons of trigeminal 
ganglia (TG) and germinal centers of pharyngeal tonsil. Periodically BHV-1 reactivates from 
latency, vin~s is shed, and consequently virus trans~nission occurs. Two viral genes, the latency 
I 
related gene and ORF-E are abundantly expressed during latency, suggesting that they regulate 
the latency-reactivation cycle. The ability of BHV-1 to enter permissive cells, infect sensory 
neurons and promote virus spread from sensoxy neurons to rnucosal surfaces following 
reactivation from latency is also regulated by severz~l viral glycoproteins. The focus of this 
review is to sun~marize the biology of BHV-1 and how this relates to BRDC. 
t Keywords: bovine herpesvin~s type 1 (BHV-I), bovine respiratory disease complex (BIIDC), 
pneumonia, immune suppression, latency, pathogenesis 
Disease and clinical symptoms induced by bovine 
herpesvirus type 1 (BHV-1) 
I 
BHV-1 is an a-herpesvirin'le subfamily mernber that 
Causes significant economical losses to the cattle industry 
(Turin et al., 1999). Three BIIV-1 subtypes, BHV-1 1 (11, 
BHV-1.2a (2a) and BHV-1.2b (Zb), have been ~clentlfied 
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based on antigenic and genomic analysis (Metzler et nl., 
1985). Subtype 1 v in~s  isolates are the causative agents of 
infectioits boxrine rhinotracl~eitis (IBR) and are Freq~lently 
found in the respiratory tract as well as aborted fetuses. 
Subtype 1 strains are prevalent in Europe, North America 
and South America. Subtype 2a is frequently associated 
with a broad range of clinical manifestations in the 
respiratory and genital tracts such as IBR, infectious 
pustular vl~lvovaginitis (IPV), balanopostitis (IPB) and 
abortions (Oirschot, 1995). Subtype 2a is prevalent in 
Brazil and was present in Europe prior to the 1970s 
(Oirschot, 1995). Subtype 2b strains are associated with 
respiratory disease and IPV/IPB, but not abortion 
(Oirschot, 1995; D'Arce et al., 2002). Subtype 2b strains 
are less pathogenic than subtype 1 and are frequently 
isolated in Australia or Europe, but not Brazil (Edwards 
et al., 1990). 
In feedlot cattle, the respiratory form of BHV-1 is the 
most common (subtype 1 strains). In breeding cattle, 
abortions or genital infections tend to be more common. 
Genital infections can occur in bulls (IPB) and cows (IPV) 
within 1-3 days of mating or close contact with an 
infected animal. Transmission can also occur in the 
absence of visible lesions and through artificial insemina- 
tion with semen from sub-clinically infected bulls. 
The incubation period for the respiratory and genital 
forms of BHV-1 is 2-6 days (Yates, 1982). With respect to 
respiratory disease, clinical symptoms include high fever, 
anorexia, coughing, excessive salivation, nasal discharge, 
conjunctivitis with lacrimal discharge, inflamed nares, and 
dyspneae if the larynx becomes occluded with purulent 
material. Nasal lesions consist of numerous clusters of 
grayish necrotic foci on the mucous membrane of septa1 
mucosa. In the absence of bacterial pneumonia, recovery 
typically occurs 4-5 days after the onset of clinical 
symptoms. Abortions can occur at the same time as 
respiratory disease, but may also be seen up to 100 days 
after infection, which is likely due to reactivation from 
latency. 
With respect to genital infections, the first clinical signs 
are frequent urination and a mild vaginal infection (Yates, 
1982). It is also common to observe swollen vulva or 
small papules followed by erosions and ulcers on the 
mucosal surface. In bulls, similar lesions occur on the 
penis and prepuce. If secondary bacterial infections 
occur, there may be inflammation of the uterus and 
transient infertility with purulent vaginal discharge for 
several weeks. In the absence of bacterial infections, 
animals usually recover within 2 weeks after infection. 
Regardless of the involvement of secondary bacterial 
infection, BHV-1 establishes lifelong latency following 
acute infection. 
The seroprevelance of BHV-1 ranges from 14 to 60% in 
Africa and from 36 to 48% in Central and South America 
(Straub, 1990). In The Netherlands, 49% of cows that give 
birth to their first calf are seropositive, whereas 91% of 
older cows are seropositive (Wuyckhuise et al., 1994). 
Serological testing and removal of infected animals 
has been successfully used to eliminate BHV-1 from 
Denmark, Switzerland and Austria (Ackermann and 
Engels, 2005). In these countries, cattle populations are 
relatively small and movement of cattle can be controlled. 
With respect to the United States and other countries, 
eradication would be difficult, perhaps impossible, and 
very expensive. 
The seroprevalence of BHV-1 in bison raised on a 
ranch is 43.8% (Sausker and Dyer, 2002), indicating that 
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infection can readily occur in bison. One would assume 
that BW-1 is readily transmitted from buffalo to cattle 
and vice versa. Since more buffalo meat is being 
consumed each year in the United States, BHV-1 
infections will have an impact on the emerging bison 
industry. It is not clear what the percentage of sero- 
positive animals is due to vaccination. Nevertheless, it is 
clear that BHV-1 is widely disseminated in the field. 
Relationship between BHV-1-induced immune 
suppression and bovine respiratory disease 
Bovine respiratory disease complex (BRDC), also referred 
to as 'shipping fever', costs the US cattle industry at 
least $3 billion (Tikoo et al., 1995a, b; National 
Agricultural Statistics Service (NASS), 1996; Bowland and 
Shewen, 2000). In addition to the clinical symptoms 
described above for BHV-1, BHV-1 can initiate BRDC by 
transiently suppressing the immune system of infected 
cattle (Yates, 1982). BHV-I-induced immune suppression 
leads to secondary bacterial infections (Pasteurella 
haemolytica, Pasteurella multocida and Haemophilus 
somnus for example) that can cause pneumonia (Yates, 
1982). Increased susceptibility to secondary infection 
correlates with depressed cell-mediated immunity after 
BHV-1 infection (Griebel et al., 1987a, b, 1990; Carter 
et al., 1989). c D ~ '  T-cell recognition of infected cells 
is impaired by repressing expression of major histocom- 
patibility complex (MHC) class I and the transporter 
associated with antigen presentation (Hariharan et al., 
1993; Nataraj et al., 1997; Hinkley et al., 1998). CD4' T-cell 
function is impaired during acute infection of calves 
because BHV-1 infects CD4' T-cells and induces apop- 
tosis (Winkler et al., 1999). Two viral genes, bICPO and 
UL41.5, can inhibit specific immune responses in the 
absence of other viral genes. A discussion of these genes 
and how they inhibit immune responses is provided 
below. 
The blCPO protein activates viral gene expression 
and inhibits interferon (IFN) signaling pathway 
The bICPO protein is the major transcriptional regulatory 
protein because it activates expression of all viral pro- 
moters (Everett, 20001, and the bICPO transcript is 
constitutively expressed during productive infection 
(Fraefel et al., 1994). The ICPO homologues encoded by 
BHV-I and herpes simplex virus type 1 (HSV-1) contain a 
well-conserved C3HC4 zinc RING finger near their 
respective N-termini (Fig. 1A). Mutational analysis has 
demonstrated the importance of the C3HC4 zinc RING 
finger domain of bICPO and ICPO (Everett, 1987, 1988; 
Everett et al., 1993; Inman et al., 2001~). ICPO (Maul et al., 
1993; Maul and Everett, 1994; Everett et al., 1997, 1999a, 
b) and bICPO (Parkinson and Everett, 2000; Inman 
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Fig. 1. Schematic of blCPO, LR gene and ORF-E genes within the BHV-1 genome. (A) schematic of BHV-1 genome, location of 
blCPO and ORF-E. Domains within blCPO include an NLS (nuclear localization sequence), TAD (transcriptional activation 
domain), acidic domain and the C3HC4 zinc RING finger. (B) The start sites for LR-RNA transcription during latency and 
productive infection were previously described (Devireddy and Jones, 1998; Hossain eta/., 1995). The C-termini of blCPO and 
ORF-E overlap the LR gene and are antisense with respect to blCPO and ORF-E. Reading frames B and C (RF-B and RF-C) each 
contain an open reading frame (ORF) that lacks an initiating Met. The (*) denotes the position of stop codons that are in frame 
with the respective ORF. 
et al., 2001~) colocalize with and disrupt the proto- 
oncogene promyelocytic leukemia protein-containing 
nuclear domains. Disruption of the bICPO zinc RING 
finger prevents trans-activation of a simple viral promoter 
(Zhang and Jones, 2005) and impairs the ability of bICPO 
to stimulate plaque formation following transfection 
of BHV-1 DNA into cultured bovine cells (Inman et al., 
2001c; Geiser and Jones, 2003). The bICPO protein 
contains two transcriptional activation domains (TAD) 
and a nuclear localization signal (NLS) that is necessary 
for efficient transcriptional activation (Zhang and 
Jones, 2005) (Fig. 1A). Unlike most transcription factors, 
bICPO or ICPO does not apparently bind to specific 
DNA sequences, suggesting that bICPO activates trans- 
cription by interacting with cellular transcriptional 
machinery. Support for this prediction comes from 
the finding that bICPO associates with chromatin re- 
modeling enzymes, histone deacetylase 1 (HDACI) 
(Zhang, 2001) and p300, a histone acetyl transferase 
(Zhang and Jones, 2001). The ability of bICPO to associate 
with HDACl and p300 correlates with activating viral 
transcription. 
In the absence of other viral genes, blCPO inhibits IFN 
signaling (Henderson et al., 2005). bICPO (directly or 
indirectly) reduces IRF3 (IFN regulatory factor 3) protein 
levels in human or bovine cells, which consequently leads 
to reduced IFN-P promoter activity (Saira et al., 2007). 
In addition, bICPO inhibits the ability of IRF7 to activate 
IFN-P promoter activity, but bICPO does not dramatically 
reduce IRF7 protein levels (Saira et al., 2007). The RING 
finger of ICPO (Van Sant et al., 2001; Boutell et al., 2002; 
Boutell and Everett, 2003) and bICPO (Dia et al., 2005) is 
an E3 ubiquitin ligase, suggesting that the bICPO RING 
finger mediates IRF3 degradation. The finding that a 
functional proteasome is necessary for bICPO-induced 
IRF3 degradation (Saira et al., 2007) supports the notion 
that the bICPO RING finger mediates IRF3 degradation. 
The RING finger is not the sole component necessary 
for bICPO-induced IRF3 degradation because specific 
mutations near the C-terminus of bICPO are also important 
(Saira et al., 2007). Additional studies are necessary to 
understand how bICPO inhibits IRF7 induction of IFN-P 
promoter activity as well as the mechanism by which 
bICPO induces IRF3 degradation. 
What role does IRF3 play during IFN production, and 
why is it important for bICPO to target IRF3 functions? 
Following virus infection, two cellular protein kinases, 
IKK-E or TBK-1, phosphorylate serine residues at the 
C-terminus of IRF3, which induces IRF3 homodimeriza- 
tion and nuclear translocation (Fitzgerald et al., 2003; 
Sharma et al., 2003). Nuclear IRF3 associates with other 
transcriptional activators resulting in direct binding 
and stimulation of IFN-P promoter activity (Wathelet 
et al., 1998). IRF3 also directly binds several consensus 
DNA-binding sites, including ISRE (IFN response 
elements), and can consequently stimulate transcription 
of IFN-stimulated genes in the absence of IFN (Guo et al., 
2000; Mossman et al., 2001). IRF3 activation is an 
immediate early regulator of the IFN response, whereas 
IRF7 is believed to be a component of the early response 
(Yoneyama et al., 1998; Yuang et a[., 1998; Sato et a/., 
2001). Surprisingly, IRF7 is more important with respect to 
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Fig. 2. Schematic of the BHV-1 gN protein. Predicted amino acid sequences of the BHV-1 gN (UL49.5) protein (120). 
Predicted signal sequence amino-terminal 22 amino acids (shaded letters), luminal domain (dashed line) and transrnembrane 
domain (underlined) are indicated. Conserved cysteine residue (C42) within the luminal domain and a cysteine residue within 
the transmembrane domain are boxed. 
inhib~ting viral infection when IRF3 versus IKF7 knockout 
mice are compared (Honda et al., 2005). Since BHV-1 
does not grow in mice unless they lack IFN receptors 
(Abril et al., 2004), it is clear that the ability of BHV-1 to 
inhibit innate immune responses, IFN for example, is 
cnicial for pathogenesis in cattle and host range. 
The BHV-1 UL49.5 open reading frame (ORF), also 
known as glycoprotein N (gN), encodes a 96-amino-acid 
protein with an apparent molecular mass of 9 kDa (Liang 
et al., 1993). The UL49.5 ORF contains a signal peptide 
(N-terminal 22 amino acids), an extracellular domain of 
32 amino acids, a transmembrane region of 25 amino 
acids and a 17 amino acids long cytoplasmic tail (Liang 
et al., 1993) (Fig. 2). The LJL49.5 protein is expressed as a 
non-glycosylated type I membrane protein (Liang et al., 
1993, 1996). 
All gN herpesvirus orthologues studied to date form 
complexes with glycoprotein M (gM), which is encoded 
by the ULlO ORF Uons et al., 1998; W'u et al., 1998; 
Rudolph et al., 2002). gM is important for secondary 
envelopment because in PRV secondary envelopment in 
the Golgi and subsequent egress require gM, in the 
absence of gE (Brack et al., 1999). The gN ho~nologues 
encoded by PRV and BHV-1 inhibit transporter-associated 
antigen processing (TAP)-mediated transport of cytosolic 
peptides into ER, which consequently blocks the 
assembly of peptide-containing ternary MHC-I complexes 
in vitm in virus-infected cells (Koppers-Lalic et al., 2005; 
Lipiriska et al., 2006). Furthermore, the BHV-1 gN targets 
the TAP complex for proteosomal degradation (Koppers- 
Lalic et al., 2005). The TAP complex consists of a 
TAPl/TAP2 heterodimer, both of which are members 
of the ATP-binding cassette transporter superfamily 
(Androlewicz et al., 1993; van Endert et al., 2002; Koch 
et al., 2004). 
Peptide transport by TAP is a critical step in MHC class I 
antigen presentation (Ahn et al., 1996; Hughes et al., 1997; 
Ambagala et al., 2004; Koppers-Lalic et al., 2005). In the 
absence of a functional TAP transporter, most MHC class I 
molecules are not loaded with peptides (Hughes et al., 
1997). However, they are retained within the ER and 
ultimately directed for degradation by the proteasome 
(Hughes et al., 1997). Structurally, both gM and TAPS are 
similar because they both contain multiple membrane 
spanning segments (Wu et al., 1998; Koch et al., 2004). A 
gN mutant that lacks the cytoplasmic tail can still I~ind to 
the TAIJ complex and Idock peptide transport, but this 
mutant gN protein does not degrade TAP (Koppers-Lalic 
et ul., 2005). However, when the transme~nbrane domain 
in addition to the cytoplasn~ic tail is truncated, gN no 
longer blocks TAP function (Koppers-Lalic et al., 2005). 
Therefore, sequences within the g N  transmeml>rane 
domain are likely to interact with TAP. The phenotype 
of a viral strain expressing the various gN mutant proteins 
has not been tested in the context of a virus and/or virally 
infected cells. In summary, the ability of gN to inhibit TAP 
is hypothesized to prevent virus-infected cells from being 
killed by CD8' T-cells. 
Viral encoded structural proteins mediate cell entry 
and pathogenesis 
To fully understand the role that BHV-1 plays in BRDC, 
one must understand how BHV-1 initiates productive 
infection. Consequently, this section summarizes what we 
know about how the virus enters cultured cells and 
disseminates in uiuo. 
a-Herpesvirus glycoproteins are required for viral 
particles to bind and penetrate permissive cells. In 
addition, a subset of viral glycoproteins is necessary for 
virus release, cell fusion and cell-to-cell spread. Ten of the 
12 BHV-1 envelope proteins (gB, gC, gD, gE, gG, gH, g1, 
gL, gM and gK) are glycosylated and two (gN and Us9) are 
non-glycosylated (Van Drunen Littel-van den Hurk and 
Babiuk, 1986; Liang et al., 1993; Baranowski et al., 1995, 
1996; Khattar et al., 1996; Schwyzer and Ackermann, 
1996; Brideau et al., 1998; Meyer etal., 1998; Mettenleiter, 
2000, 2002; Konig et al., 2002; Nakamichi et al., 2002; 
Chowdhury et al., 2006). Five envelope proteins (gB, gD, 
gH, gL and gK) are essential for growth in cultured cells, 
whereas the remaining seven (gC, gE, gG, gI, gM, gN 
and Us9) are not essential for growth in cultured cells 
(Schwyzer and Ackermann, 1996; Brideau et al., 1998; 
Butchi et al., 2007). 
All a-herpesvirus gC homologues (including BHV-1) 
facilitate attachment of virus particles to the cell surface 
by binding to heparan sulfate proteoglycan (Okazaki 
et al., 1991). In the absence of gC, gB complements the 
attachment function of gC by binding to heparan sulfate 
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(Li et al., 1995; Mettenleiter, 2002). Following initial 
attachment mediated by gB and/or gC, the next step in 
viral entry requires the interaction of gD with the cellular 
receptor nectin 1, also known as HveC (Spear, 1993, 
2004; Campadelli-Fiume et al., 2000, 2007; Spears et al., 
2000; Mettenleiter, 2002; Spear and Longnecker, 2003; 
Campadelli-Fiume and Gianni, 20061, o r  HVEM, a 
member of the tumor necrosis factor family of proteins 
(Montgomery et al., 1996). Kectin 1 belongs to a family of 
intercellular adhesion molecules whose ectodomain 
contains three immunoglobulin-like domains (Ogita and 
Takai, 2006). Certain members of the tumor necrosis 
factor family can induce apoptosis (Schmitz et al., 20001, 
suggesting that an interaction between gD and HVEM 
induces apoptosis in certain cell types (Hanon et al., 
1998). Following gD-receptor binding, gB and/or a gH-gL 
complex interacts with cellular membrane protein(s1 
leading to fusion of the viral envelope to the cell 
membrane (Pertel et al., 2001; Mettenleiter, 2002; Spear 
et al., 2006; Campadelli-Fiume et al., 2007; Reske et al., 
2007). The mechanism of viral and cellular membrane 
fusion is not well understood other than the fact that 
gD-receptor binding must occur prior to the fusion 
process (Mettenleiter, 2002; Spear et al., 2006). Viral entry 
into an adjacent cell (cell-to-cell spread) also requires gD 
because gD-deleted viruses are incapable of cell-to-cell 
spread (Fehler et al., 1992). In stably transformed cells 
expressing gD, cell-to-cell spread of wild-type (wt) virus 
is restricted (Dasika and Letchworth, 19991, suggesting 
that gD binds to putative cellular receptors, which are 
present on the apical cell membrane at the cell surface 
and lateral cell membrane located at intercellular junc- 
tions (Dasika and Letchworth, 1999; Carnpadelli-Fiume 
et al., 2000, 2007; Sakisaka et al., 2001; Campadelli-Fiume 
and Gianni, 2006). Although g1) is an essential glyco- 
protein for v in~s  entry into the cell, a compensatory 
mutation in gH at amino acid residue 450 (mutation of 
glycjne to tryptophan) mediates gD-independent entry 
and cell-to-cell spread of a g1)-cleleted virus (Schroder 
et al., 1997). 
Interactions between gE and gI also promote cell- 
to-cell virus spread, and gE and/or gI deletion mutants arc 
defective in cell-to-cell spread (Dingwell and Johnson, 
1998; Cho~vdhury et al., 1999; Mettenleiter, 2000, 2002). 
Based on results from HSV-1 studies, it appears that gE 
binds to a putative cellular receptor located at cellular 
junctions (Dingwell and Johnson, 1998). Of the non- 
essential envelope proteins, gE has received a lot of 
attention because it is required for anterograde neuronal 
spread in oirjo and neurovinrlence (Enquist et nl., 1999). 
gE-deleted viruses are transported retrograclely from the 
nose and eye via the maxillary anti ophthalmic bmnch of 
trigeminal ganglia (TG) where they establish latency in 
sensory neurons (Enquist et al., 1999; Chowdhury et al., 
2000; Liu et al., 2007). gE-deleted viruses do not reactivate 
from latency because they cannot spread in an 
anterograde direction from sensory neurons in TG to 
non-neuronal cells in the nose or ocular cavity (Enquist 
et al., 1999; Liu et al., 2007). 
The envelope protein (Us9) is also important for 
anterograde neuronal spread because calves latently 
infected with Us9-deleted viruses do  not shed virus 
in the nose and eye following dexamethasone- 
induced reactivation (Butchi et al., 2007). Interestingly, 
Us9-deleted BHV-1 and pseudorabies virus (PRV) do  not 
have a phenotype following infection of epithelial cells in 
culture (S. I. Chowdhury, unpublished data). With respect 
to PRV, the Us9-deleted virus has a defective anterograde 
neuronal spread phenotype because in the absence 
of Us9, axonal transport of viral glycoproteins or 
vesicles containing viral glycoproteins does not occur 
(Tomishama and Enquist, 2001). Therefore, the Us9 
function is neuron-specific and is required only in the 
context of anterograde neuronal transport. 
BHV-1 gG is secreted after proteolytic processing. In 
addition, gG is present o n  the virus envelope and is 
associated with infected cell membranes (Bryant et al., 
2003). Like other a-herpesvirus gG homologues, the 
BHV-1 gG has chemokine binding activity because it 
blocks the interaction of chemokines with cellular 
receptors and glycol-aminoglycans (GAGS). The chemo- 
kine binding activity of gG also occurs o n  cell membranes 
because membrane-anchored forms of gG bind to various 
chemokines (Bryant et al., 2003). Deletion of the 
BHV-1 gene encoding gG leads to viral attenuation in 
calves because the mutant virus is more immunogenic 
(Kaashoek et a/., 1996b). The chemokine binding activity 
encoded by BHV-1 gG is responsible for the attenuated 
phenotype following infection of calves (Bryant et al., 
2003). In summary, these studies indicate that numerous 
viral genes are necessary for initiating productive 
infection and cell-to-cell spread. 
The BHV-1 latency-reactivation cycle of BHV-1 
Acute infection leads to high levels of virus 
production 
In the field, it is recognized that BRDC is not always 
associated with acute BFIV-1 infection. It is generally 
believed that the ability of BHV-1 to reactivate from a 
latent infection can initiate BRDC. The goal of this section 
is to summarize our current knowledge of the BHV-1 
latency-reactivation cycle. 
Acute BHV-1 infection is initiated on nlucosal surFdces 
and resirlts in high levels of programmed cell death 
(Wlnkler et al., 1999). Infection of permissive cells 
(Devireddy and Jones, 1999) with BHV-1 also leads to 
rapid cell death, in part, due to apoptosis. Viral gene 
expression is temporally regulated in three distinct 
phases: immediate early (IE), early (El or late (L). IE 
gene expression is sti~nulated by a virion component, 
a-TIF (Misra et nl., 1995). Two IE transcription units exist: 
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Acute infection 
(High levels of infectious virus) 
Establishment of latency Neuronal death? 
LR gene inhibits apoptosis 
LR gene inhibits productive infection 
OW-E enhances neuronal 'health' 
Neuronal factors also inhibit productive infection 
CMI response in TG 
Maintenance of latency 
v LR gene expression LR gene inhibits apoptosis Reactivation from latency LR gene inhibits bICPO RNA expression Reduced LR and ORF-E gene expression 
ORF-E enhances neuronal 'health' Increased viral gene expression--> infectious virus 
Stress (increased corticosteroids) 
Immune suppression 
Fig. 3. Summary of BHV-1 latency-reactivation cycle. For details, see the subsection 'Summary of the latency-reactivation 
cycle in cattle'. 
IE transcription unit 1 (IEtul) and IEtu2. IEtul encodes 
functional homologues of two HSV-1 IE proteins, ICPO 
and ICP4. IEtu2 encodes a protein that is similar to the 
HSV IE protein, ICP22 (Wirth et al., 1991). In general, IE 
proteins activate E gene expression, and then viral DNA 
replication occurs. L gene expression is also activated 
by bICPO, culminating in virion assembly and release. 
As discussed above, bICPO is important for productive 
infection because it transcriptionally activates all viral 
promoters, .and is expressed at high levels throughout 
infection (Wirth et al., 1991, 1992; Fraefel et al., 1994). 
Acute infection leads to high levels of virus production 
and secretion in ocular, oral or nasal cavities. If acute 
infection is initiated in the genital tract, virus shedding can 
be readily detected in genital'tissues. Regardless of the 
site of infection, virus shedding can last for 7-10 days after 
infection (Jones, 1998, 2003). 
Summary of the latency-reactivation cycle in cattle 
Viral particles, or perhaps subviral particles, enter the 
peripheral nervous system via cell-cell spread. If infection 
is initiated via the oral cavity, nasal cavity or ocular orifice, 
the primary site for latency is sensory neurons within TG. 
Relatively high levels of viral gene expression (Schang 
and Jones, 1997) or infectious virus (Inrnan et al., 2002) 
can be detected in TG from 1-6 days after infection (see 
Fig. 3, for a summary of the latency-reactivation cycle of 
BHV-1). Viral gene expression and detection of infectious 
virus are subsequently extinguished, but viral genomes 
can be detected in TG (establishment of latency). In 
contrast to productive infection in cultured cells, a 
significant number of infected neurons survive, and these 
neurons harbor latent genomes. A hallmark of latency is 
the abundant level of transcription that occurs from the 
latency related (LR) gene (Jones, 1998, 2003; Jones et al., 
2006) and ORF-E (Inman et al., 2004). It appears that the 
LR transcript is the first viral transcript expressed in 
infected neurons because we have detected a spliced LR 
transcript in TG at 24 h after calves were infected 
(Devireddy and Jones, 1998). In contrast, we were not 
able to detect IE or E gene expression at the same time 
using sensitive RT-PCR assays, suggesting that LR gene 
products play a pivotal role in programming the outcome 
of virus infection in sensory neurons. Support for this 
prediction comes from the finding that LR gene products 
promote establishment of latency by inhibiting apoptosis 
(Ciacci-Zanella et al., 1999; Henderson et al., 2004) and 
viral gene expression (Bratanich et al., 1992; Geiser et al., 
2002). ORF-E may promote efficient establishment of 
latency because it can induce neurite-like outgrowth in 
mouse neuroblastoma cells (Perez et al., 2007). Conse- 
quently, ORF-E may enhance restoration of mature 
neuronal functions following infection. During main- 
tenance of latency, infectious virus is not detected using 
standard virological methods. Since the LR gene and 
ORF-E are abundantly expressed during the maintenance 
of latency, they are predicted to play an active role in 
maintaining latency. 
Elevated corticosteroid levels (stress) and/or immune 
suppression can initiate reactivation from latency. The 
stress associated with moving cattle from one location to 
another is one obvious stimulus that can trigger reactiva- 
tion from latency and BRDC. During reactivation from 
latency, three significant events occur: (i) productive viral 
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gene expression is readily detected in sensory neurons, 
(ii) ORF-E and LR gene expression decrease dramatically 
and (iii) infectious virus is secreted from nasal or ocular 
swabs (Jones, 1998, 2003; Jones et al., 2006). Adminis- 
tration of dexamethasone to calves or rabbits latently 
infected with BHV-1 reproducibly leads to activation of 
viral gene expression and reactivation from latency (Rock 
et al., 1992; Jones, 1998; 2003; Jones et al., 2000, 2006; 
Inman et al., 2002). Although many latently infected 
neurons do not apparently produce infectious virus, a 
much higher number of neurons are detected in which 
viral gene expression occurs (Rock et al., 19921, suggest- 
ing that virus-producing neurons are not common. 
Non-neural sites of latency-persistence in cattle 
Although establishment of latency in ganglionic neurons 
is the main site of latency for BHV-1 and other 
a-herpesvirinae subfamily members, latent or persistent 
infections also occur in non-neural sites, tonsils and 
lymph nodes for example. BHV-1 DNA is consistently 
detected in tonsils (Winkler et al., 20001, peripheral blood 
cells (Fuchs et al., 19991, lymph nodes and spleen of 
latently infected calves, even when infectious virus is not 
detected (Mweene et al., 1996). Pseudorabies virus (Sabo 
and Rajanci, 1976; Cheung, 1995), equine herpesvirus 
type 4 (Borchers et al., 1999) and canine herpesvirus type 
1 (Miyoshi et al., 1999) DNA is also detected in lymphoid 
tissue during latency. It remains to be seen what 
non-neural cell types are latently infected with BHV-1, 
and whether viral genes are expressed in these latently 
infected cells. In contrast to latency in sensory neurons, 
LR-RNA is not abundantly expressed in latently infected 
lymphoid tissue (Winkler et al., 2000). Infectious virus can 
be detected when germinal centers from tonsil of latently 
infected calves are explanted (Perez et al., 2005) adding 
support to the hypothesis that BHV-1 has established a 
latent or persistent infection in cells of lymphoid origin. 
The LR gene is abundantly expressed during latency 
and is necessary for the latency-reactivation cycle 
As discussed above, LR-RNA is abundantly transcribed in 
latently infected neurons (Rock et al., 1987, 1992; Kutish 
et al., 1990), and is antisense relative to the bICPO gene 
(Fig. 1A). The lytic start site for LR-RNA is downstream of 
the start site used in TG (Bratanich et al., 1992; Hossain 
et al., 1995) (Fig. 1B). The LR gene has two ORFs (ORF-1 
and ORF-2), and two reading frames that lack an initiating 
ATG (RF-B and RF-C) (Fig. 1B). A peptide antibody 
directed against ORF-2 recognizes a protein encoded by 
the LR gene (Hossain et al., 1995; Jiang et al., 1998, 2004). 
A fraction of LR-RNA is polyadenylated and alternatively 
spliced in TG, suggesting that more than one LR protein is 
expressed (Hossain et al., 1995; Devireddy and Jones, 
1999). LR gene products ~nhibit cell proliferation, bICPO 
RNA expression (Bratanich et al., 1992; Schang et al., 
1996; Geiser et al., 20021, and apoptosis (Ciacci-Zanella 
et al., 1999). LR protein expression is necessary for 
inhibiting apoptosis, but not cell growth (Geiser and 
Jones, 2005) or bICPO expression (Bratanich et al., 1992; 
Schang et al., 1996; Geiser et al., 2002). 
A mutant BHV-1 strain with three stop codons at the 
N-terminus of ORF-2 (Inman et al., 2001b) does not 
express ORF-2 or RF-C following infection of bovine cells 
(Jiang et dl., 2004). As expected, wt or the LR rescued 
virus express ORF-2 and RF-C. Calves infected with the LR 
mutant virus exhibit diminished clinical symptoms, and 
reduced shedding of infectious virus from the eye, TG or 
tonsil (Inman et al., 2001b, 2002; Perez et al., 2005). The 
LR mutant virus does not reactivate from latency follow- 
ing treatment with dexamethasone, whereas all calves 
latently infected with wt virus or the LR rescued virus 
shed infectious virus following dexamethasone treatment 
(Inman et al., 2002). Thus, the LR gene is necessary for the 
latency-reactivation cycle in calves. It is not clear whether 
LR proteins are necessary for stimulating reactivation from 
latency or whether these products establish and maintain 
latency in .a pool of neurons that are capable of 
supporting reactivation from latency. 
Previous studies determined that the LR transcript is 
alternatively spliced in TG during acute versus latent 
infections (Devireddy and Jones, 1998; Devireddy et al., 
2003). A novel alternatively spliced cDNA is expressed in 
TG at 7 days after infection (7d cDNA), which is the 
transition from acute infection to establishment from 
latency. The 7d cDNA has the potential to encode the 
N-terminal domain of ORF-2 fused to ORF-I, suggesting 
that this novel fusion protein promotes establishment of 
latency. The 7d cDNA was used in a two-hybrid screen to 
identify cellular proteins that interact with the novel LR 
fusion protein encoded by the 7d cDNA (Meyer et al., 
2007). The LR fusion protein interacts with two proteins 
that can induce apoptosis (Bid and Cdc42), and with the 
CCAAT enhancer-binding protein a (C/EBP-a). Bid links 
the extrinsic pathway of apoptosis to the intrinsic 
pathway because following cleavage by caspase 8, Bid 
interacts with mitochondria (Li et al., 19981, which leads 
to cytochrome c and Smac/Diablo release (Wang, 2001). 
Bid is also specifically cleaved by granzyme B (Barry 
et al., 2000; Alimonti et al., 2001; Pinkoski et al., 2001), 
suggesting that the ability of LR proteins to interact with 
Bid impairs cytotoxic T-lymphocyte (CTLI-induced death 
of infected neurons. Neuronal stress, including removal of 
nerve growth factor from neuronal cultures (Kanamoto 
et al., 2000; Xu et al., 2001), induces Cdc42 activity, a Rho 
GTPase family member (Harwood and Braga, 2003). 
When PC12 cells (rat neuronal-like cell line) are treated 
with nerve growth factor, they differentiate and behave 
like mature sympathetic neurons (Greene and Tischler, 
1976; Greene et al., 1987). If PC12 cells or primary 
sympathetic neurons are deprived of nerve growth factor, 
Cdc42 is activated resulting in apoptosis (Kanamoto et al., 
2000; Xu et a/., 2001). Since dexamethasone is a potent 
stressor and reproducibly induces BHV-I reactivation 
from latency (Sheffy and Davies, 1972; Ackerrnann et al., 
1982; Homan and Easterday, 1983; Ackermann and Wyler, 
1984; Brown and Field, 1990; Rock et al., 1992; Jones 
et al., 2000; Winkler et al., 2002), Cdc42 may be activated 
in TG. 
The interaction between the LR fusion protein and 
C/EBP-ol may also influence BHV-1 gene expression 
because C/EBP-a stimulates lytic gene transcription of 
other herpesviruses, EBV, HHV-8 and HVS for example 
(Wang et al., 2003b; Wu et al., 2004; Wakenshaw et al., 
2005; Huang et al., 2006). Three lines of evidence support 
the finding that C/EBP-a enhances BHV-I productive 
infection: (i) C/EBP-a protein expression is stimulated 
during productive infection, (ii) there is a positive 
correlation between viral gene expression in TG and 
C/EBP-a protein expression and (iii) wt C/EBI-'-a, but not 
a DNA binding mutant, enhances BHV-1 plaque for~na- 
tion (Meyer et al., 2007). It will be of interest to determine 
whether CIEBP-a directly stimulates viral promoters or if 
it indirectly activates productive infection. 
The BHV-I LR gene and HSV-1 LAT (latency-associated 
transcript) share structural and functional properties. For 
example, LR-RNA and LAT are transcribed in an antisense 
direction of bICP0 and ICPO respectively, and both are 
abundantly expressed during latency (Rock et al., 1987; 
Kutish et al., 1990; Hossain et al., 1995; Schang and Jones, 
1997; Devireddy and Jones, 1998; Winkler et al., 2000). 
Furthermore, the LR gene (Ciacci-Zanella et al., 1999) and 
LAT (Perng et al., 2000; Inman et al., 2001a; Ahmed et al., 
2002) inhibit apoptosis. To test whether the LR gene 
restores spontaneous reactivation to a HSV-1 LAT deletion 
mutant (dLAT2903), a 2 kb fragment containing the LR 
promoter and LR coding sequences was inserted into 
the LAT locus of dLAT2903, and the recombinant virus 
designated CJLAT (Perng et al., 2002). Insertion of the LR 
gene into the HSV-1 LAT locus restores high levels of 
spontaneous reactivation in the rabbit eye model and in 
explant-induced reactivation. Rabbits infected with CJLAT 
have higher levels of recurrent eye disease (stromal 
scarring and detached retinas). Further evidence for the 
expanded pathogenic properties of CJLAT came from the 
finding that CJLAT is more lethal in mice relative to LAT+ 
or LAT- strains of HSV-1. In contrast, insertion of the LR 
gene with stop codons into dLAT2903 generated a virus 
that behaves like the parental LAT-null mutant adding 
further support that LR protein expression regulates the 
latency-reactivation cycle (Mott et al., 2003). 
ORF-E encodes a protein that is expressed in TG 
of latently infected calves 
A small ORF that is present within the LR promoter has 
been designated OW-E (Fig. 1A). OW-E is antisense to 
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the LR transcript and downstream of the blCPO ORF. A 
transcript that encompasses ORF-E is expressed in 
productively infected bovine cells and TG of latently 
infected calves (Inman et al., 2004). When ORF-E protein 
coding sequences are fused in frame with green 
fluorescent protein (GFIJ) sequences, GFP protein expres- 
sion is detected in the nucleus of mouse or human 
neuroblastoma cells. In contrast, the ORF-E-GFP fusion 
protein is expressed throughout rabbit skin cells. 
I'olyclonal antiserum directed against an ORF-E peptide 
or the entire ORF-E protein specifically recognizes the 
nucleus of sensory neurons in TG of latently infected 
calves and mouse neuroblastoma cells transfected with an 
OKF-E-expressing plasmid (Perez et ul., 2007). ORF-E also 
induces neurite-like projections in these same mouse 
neuroblastoma cells. In contrast, neurite-like projections 
are not olxerved following transfection of rnouse 
neuroblastoma cells with an empty vector, suggesting 
that OIIF-E induces changes in the physiology of neuronal 
cells. It mrill be  necessary to construct a BHV-1 mutant that 
does not express the ORF-E protein to test whether ORF-E 
plays a role in the latency-reactivation cycle. 
Immune response to BHV-1 following acute infection 
Although BHV-1 has the potential to immune-suppress 
cattle, a potent immune response ultimately occurs, 
which prevents systemic infection. With respect to BRDC, 
this implies that immunosuppression initiated by BHV-1 is 
short-lived. 
The host immune response to BHV-1 jnfection includes 
innate and adaptive immune responses (Rouse and 
Babiuk, 1978). Innate immune responses include the 
antiviral action of IFN, alternative complement pathway 
and local infiltration of lymphoid cells, macrophages, 
neutrophils or natural killer (NK) cells for example. 
Following BHV-1 infection, IFN-a and IFN-P are 
detectable in nasal secretions as early as 5 h post- 
infection, reach a maximum level at 72-96 h post- 
infection and can persist for up to 8 days after infection 
(Straub and Ahl, 1976). During early times after infection, 
IFN-a and IFN-P promote leukocyte migration, activate 
macrophages and increase NK cell activity (Babiuk et al., 
1985; Lawman et al., 1987; Jensen and Schultz, 1990). 
Activation of macrophages and increasing NK cell activity 
stimulate cytolytic activities against virus-infected cells 
(Rouse and Babiuk, 1978). NK cells are a diverse 
population of non-adherent effecter cells that lack T- and 
B-cell markers (Cook and Splitter, 1989). These cells 
require a long incubation period with the target cell for 
optimum lysis (Campos and Rossi, 1986). In addition, 
NK-like cytotoxicity is also associated with a population 
of CD3' CD45', Fc receptor-positive lymphocytes, which 
may represent a subset of y6 T-cells (Arnadori et al., 1992). 
Adaptive or humoral immune responses lead to produc- 
tion of neutralizing antibodies that bind virus particles and 
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inhibit productive infection. Envelope glycoproteins gB, 
gC, gD and gH are the most potent inducers of virus 
neutralizing antibodies (Van Drunen Littel-van den Hurk, 
1986; Marshall et al., 1988). In addition, non-neutralizing 
antibody may mediate the destruction of enveloped virus 
or cells expressing viral proteins on the cell membranes, 
and this process is referred to as antibody-mediated cell 
cytotoxicity (Van Drunen Littel-van den Hurk et al., 1993). 
Neutralizing and non-neutralizing antibodies produced 
against envelope proteins can also inhibit virus infection by 
several distinct mechanisms: (i) membrane attack complex 
(MAC) lysis of virus envelope and virus-infected cells 
mediated by antibody and complement and (ii) antibody- 
mediated cell cytotoxicity in which either IgG interacts 
with Fc receptor-positive cells (macrophages) or (iii) 
binding of C3b to IgM mediates binding to C3b receptor- 
positive cells (lymphocytes, macrophages). In all cases, 
virus-infected cells are lysed (Rouse et al., 1976, 1977a, b; 
Rouse and Babiuk, 1977, 1978). Production of virus 
neutralizing and non-neutralizing antibodies (IgG) can 
be detected 8-12 days post-infection (Rouse and Babiuk, 
1978). Local/mucosal immunity depends on secreted 
neutralizing antibodies (IgA molecules) and systemic 
humoral immunity depends on IgG. 
Cell-mediated immune (CMI) responses play an 
important role in killing virus-infected cells that express 
viral antigens on the cell surface (Van Drunen Littel-van 
den Hurk, 2007). For example, a C D ~ '  CTL response is an 
important defense against BHV-I because cell-to-cell 
spread in upper respiratory epithelium occurs before 
hematogenous spread (Van Drunen Littel-van den Hurk, 
2007). Cytotoxic and proliferatve T lymphocyte responses 
occur in the blood approximately 8 days after infection. 
CTL responses have been induced by gB and gD DNA 
vaccines in mice (Deshpantle et al., 2002; Huang et al., 
2005). Further, gC and gD have been identified as targets 
for CTL responses in cattle (Denis et al., 1993) and gB 
DNA vaccines elicit a CTL response in cattle (Huang et al., 
2005). Other structural ancl non-str~ict~iral vild proteins 
may also play a role in CiVfI response because only a 
limited number of BHV-1 proteins have been evaluated 
for CTL activity (Van Drunen Littel-van den Hurk, 2007). 
In addition to destruction of infected cells, T-lymphocytes 
release a number of lymphokines that moclul;~te specific 
and non-specific immune response. For example, IFN-y 
and other factors that further activate macrophages 
(Campos et al., 1989) are produced. BIIV-I proteins 
(gB-, gC-, gD- and VI'8) are recognizcd Ily CD-I' T helper 
cells from immune cattle (Hutchings rt nl., 1990). Cells 
expressing gB, gC or gD on their membranes have also 
been identified as targets for cD4' T-cells (Leary and 
Splitter, 1990; Tikoo et al., 1995a, b). Fhally, CDi' T-cells 
are important for the developnlent of antibody response 
and for developing effective CD8' T-cell memory 
Uanssen et al., 2003; Shedlock and Shen, 2003). There- 
fore, both C D ~ '  and C D ~ '  T cells as well as antibodies are 
required for long-term protection. 
A prolonged CMI response occurs in the peripheral 
nervous system during latency 
Several independent studies have demonstrated that 
T-cells, C D ~ '  T-lymphocytes in particular, control HSV-1 
infection in sensory ganglia during latency (Nash et al., 
1987; Simmons and Tscharke, 1992; Simmons et al., 1992; 
Cantin et al., 1995; Shimeld et al., 1995; Halford et al., 
1996; Liu et al., 1996; Shimeld et al., 1996, 1997). Viral 
antigen-positive neurons surrounded by non-neural cells 
expressing TNF-a, IL-2, IL-6, IL-10 or IFN-y can also be 
detected in mice latently infected with HSV-1 (Halford 
et al., 1996; Liu et al., 1996; Shimeld et al., 1997). No cells 
with lymphoid cell morphology are detected in TG of 
uninfected mice. A persistent infiltration of lymphoid cells 
in sensory ganglia and spinal cord is also detected in mice 
or guinea pigs latently infected with HSV-2 (Milligan et al., 
2005). Following infection of calves with BHV-1, foci of 
infiltrating lymphocytes can be readily detected during 
acute infection (Winkler et al., 2002). Finally, in human 
TC latently infected with HSV-1, a chronic immune 
response has also been observed (Theil et al., 2003; 
Verjans et al., 2007). Collectively, these studies indicate 
that long-term persistence of T-cells in sensory ganglia 
during latency has the potential to regulate the latency- 
reactivation cycle. 
Persistence of immune cells in TC may be due to 
viral protein expression in a rare neuron or satellite cell. 
Careful examination of TG neurons for viral gene 
expression in HSV-1 latently infected mice (37-47 days 
after infection) demonstrated that abundant viral tran- 
scripts, viral protein and viral DNA replication occur in 
approxin~ately 1 neuron per 10 TG (Feldman et al., 2002). 
Infectious virus is not detected in these mice, confirming 
that they are latently infected. Neurons expressing high 
levels of HSV-1 transcripts are invariably surrounded by 
foci of infiltrating white blood cells. The term 'sponta- 
neous molecular reactivation' has been coined to describe 
these rare neurons (Feldman et al., 2002). Rare cells in TG 
of calves latently infected with BHV-I can be detected 
that express viral transcripts and proteins (Winkler et al., 
20021, suggesting that mo~ecular spontaneous reactivation 
occurs during BHV-1 latency. 
CDH' T-cells that produce IFN-y are believed to play an 
important role in preventing reactivation from latency in 
sensory neurons in mice latently infected with HSV-1 (Liu 
et al., 2000, 2001). Two independent studies have also 
concluded that IFN-a and IFN-y control recurrent herpetic 
lesions (Cunningham and Mikloska, 2001; Mikloska and 
Cunningham, 2001). In addition to IFN, lymphocyte- 
mediated cytotoxicity could inhibit virus spread in TG. 
Lymphocyte-mediated cytotoxicity induces two potent 
apoptotic pathways: the granule exocytosis and the 
Fas-Fas ligand pathway (Kagi and Hengartner, 1996; 
Shresta et nl., 1998). The granule exocytosis pathway is 
employed predominantly by CD8', NK and Iynlphokine- 
activated killer cells. It appears that the BHV-1 LR gene 
plays a role in regulating lymphocyte infiltration because 
enhanced infiltration of lymphocytes occurs in TG of 
calves acutely infected with the LR mutant virus (Perez 
el al., 2006). The ability of dexamethasone to induce 
apoptosis of inflammatory cells in TG of calves latently 
infected with BHV-1 correlates with reactivation from 
latency (Winkler et al., 2002). 
BHV-1 vaccines 
Many commercially available vaccines directed against 
BHV-I can cause disease in sinall calves, in part because 
these vaccines are immunosuppressive. Consequently, 
certain vaccines have the potential to induce BRDC in 
small calves. A discussion of the current status of BHV-1 
vaccines and how they can be improved is included in the 
following paragraphs. 
Commercially available vaccines 
Commercially available vaccines directed against BHV-1 
I consist of modified live attenuated virus (MLV) or killed 
whole virus (KV) (Van Drunen Littel-van den Hurk, 2005). 
I 
In many cases, MLVs are derived by serial passage 
in tissue culture. KV vaccines are usually produced by 
chemical treatments, such as formaldehyde, P-propiolac- 
i tone or binary ethyleneimine MLVs generally induce both 
humoral and cellular immune response because virus 
1 
replication in infected cells leads to presentation of viral 
a antlgen on MHC class I+ and 11' molecules. Safety is a 
8 concern for MLVs because these strains can establish 
E latency and upon reactivation can be transmitted to 
pregnant cows, which can lead to abortion. MLVs can also 
be pathogenic in small calves because their immune 
i system is not fully developed, and most MLVs can be 
immunosuppressive. KV vaccines are usually safe but 
f they are not as efficacious because they usually produce 
i 
? only humoral immunity but no cellular immune 
i responses. Additionally, KV vaccines always require more 
i than one injection to achieve acceptable neutralizing 
antibody levels. In the case of formaldehyde-inactivated 
KV, antigens may also be denatured, which may affect the 
i immunogeniclty of vaccine preparations. KV also requires 3 suitable adjuvant formulations and some adjuvants may 
4 
f induce injection s~ t e  reactions. 
Commercially available BIN-I vaccines are primarily 
evaluated on induction of neutralizing antibodies and the 
1 
1 
f duration as well as level of virus shedding following 
challenge of vaccinated animals. As discussed earlier, the 
CMI response against the virus is important to prevent 
cell-to-cell spread of the virus. Therefore, a direct 
measure of CMI directed against a vaccine virus is i important. Traditionally, IFN-y levels in vaccinated calves 1 1 have been an indicator of cellular immune responses. 
4 However, a recent study demonstrated that there is an 
4 
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increase in CD25 by CD~ ' ,  C D ~ '  and y6T lymphocytes 
from a BHV-1 MLV-vaccinated group (Endsley et al., 
2002). Therefore, increased expression of CD25, in 
addition to IFN-y production by T-cells after vaccination, 
appears to be a useful cellular immunity marker (Van 
Drunen Littel-van den Hurk, 2007). 
Recently, there has been an apparent increase in IBR 
outbreaks in vaccinated feedlot cattle (commonly referred 
to as vaccine outbreaks) (Van Drunen Littel-van den Hurk 
et al., 2001; Ellis et al., 2005). Many of these vaccine 
outbreaks occur in feedlots that have used several 
different BHV-1 MLVs without serological markers, 
suggesting that they are not vaccine-specific. Since the 
vaccines used in the feedlots did not have any serological 
marker, it is difficult to determine by serology whether an 
animal is infected with an MLV or field strain. Thus, 
determining the source of origin from a particular vaccine 
break is not possible nor is it possible to test whether 
these outbreaks were due to changes in the vaccine strain. 
It is also possible that there is the emergence of a 
new IBR strain that is not covered by existing MLVs. A 
study investigating several isolates from such outbreaks 
determined that at least one such isolate had mutations 
within sequences comprising the gD-specific neutralizing 
epitope (Van Drunen Littel-van den Hurk et al., 2001). 
Development of genetically engineered 
gene-deleted BHV- 1 vaccines 
During the last 10-15 years, the usefulness of genetically 
engineered gene-deleted vaccines has become increas- 
ingly apparent because they can be attenuated and 
serologically distinguished from wt field strains (Van 
Drunen Littel-van den Hurk, 2005). Numerous viral 
mutants (gC-, gE-, gG-, Us9-deleted (Kaashoek et al., 
1998; Chowdhury et al., 1999; Butchi et al., 2007), 
thymidine kinase (TIC)-deleted (Chowdhury, 19%; 
Kaashoek et al., 1996a, b) and LR gene mutant virus 
(Inman et al., 2002)) have been constructed and their 
in uiuo pathogenic properties, reactivation properties and 
immunogenicity analyzed. Based on recent studies, both 
gE- and Us9-deleted viruses were safe in calves because 
they do not reactivate from latency and they are highly 
attenuated (Kaashoek et al., 1996a, b, 1998; Chowdhury 
et al., 1999; Butchi et al., 2007; Liu et al., 2007). Studies 
with gC-, gG- or TK-deleted viruses showed that they 
either reactivate from latency and/or they retain some 
degree of virulence (Kaashoek et al., 1996a, b, 1998). 
Studies with a LR mutant virus showed that the virus does 
not reactivate from latency and has reduced pathogenicity 
in calves (Inman et al., 2002). Therefore, considering the 
virulence and reactivation properties of gene-deleted 
vaccine strains, gE-, Us9-deleted or the LR mutant 
virus have the potential to be safer vaccine candidates. 
Comparative vaccine efficacy studies showed that relative 
to gC- and gG-deleted viruses, gE-deleted virus is less 
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efficacious (Kaashoek et al., 1998). However, the 
gE-deleted vaccine has been used successfully to era- 
dicate IBR from a number of European countries. 
Although the gE-deleted marker vaccine is not as 
efficacious as others noted above, it will be used until a 
better genetically engineered vaccine is developed. 
Recent efforts to improve the IBR marker vaccine are 
directed to delete viral gene sequences that are immuno- 
suppressive. As noted above, gN inhibits TAP and 
down-regulates MHC-I antigen presentation. Therefore, 
a vaccine virus lacking the gN TAP binding domain may 
stimulate better cellular immune responses. Our recent 
studies show that a gE cytoplasmic tail truncated virus is 
similarly attenuated in calves infected with the virus as the 
entire gE ORF-deleted virus. Notably, like the gE-deleted 
virus, the gE cytoplasmic tail truncated virus does 
not reactivate from latency (Liu et al., 2007). Since the 
cytoplasmic tail-specific amino acid sequences generate 
antibodies that immunoprecipitate gE, antibodies specific 
to the cytoplasmic tail sequence may serve as a sero- 
logical marker to  distinguish vaccinated versus infected 
calves (Whitbeck et al., 1996; Chowdhury et al., 2000). 
Furthermore, the Us9 gene is located immediately down- 
stream of the gE cytoplasmic tail gene; therefore, a 
recombinant BHV-1 can be constructed in which the gE 
cytoplasmic tail and the Us9 coding regions are deleted. A 
vaccine virus that lacks US9, the cytoplasmic tail of gE, and 
gN TAP binding domain may be a superior vaccine 
candidate because it: (i) should stimulate better cellular 
immune responses against BHV-1, (ii) will incorporate a 
serological marker and (iii) should not be pathogenic. 
Concerns have been raised about recombination occur- 
ring between two vaccine strains, which could lead to the 
presence of virulent viral strains in vaccinated herds (Thriy 
et al., 2005). Although it is clear that recombination can 
occur, the process requires that both viruses must replicate 
at the same time in the same cell of an infected calf. 
Vectored vaccine strains 
Intranasal vaccination of young calves with a replication 
competent (E3-deleted) bovine adenovirus (BAV)-3 
that expresses full-length BHV-1 gD inducecl protective 
gD-specific neutralizing antibodies and cellular immune 
responses (Zakhartchouk et al., 1999). Several studies also 
concluded that gD-specific bacterial plasmid-based DNA 
vaccines can serve as an effective subunit vaccine. 
Specifically, an expression plasmid that encodes the 
secreted form of gD (tgD) induces significant protection 
against BHV-1 challenge following intraderrnal injection 
(Van Drunen Littel-van den Hurk et al., 1998; Braun et nl., 
1999). Relative to killed BHV-I vaccine, the tgD DNA 
vaccine induced significant IFN-y production In PBMCs. 
Regardless of maternal antibody levels, the plasmid 
encoding tgD also triggered neutralizing antibodies, 
lymphoproliferative responses and IFN-y-secreting cells 
in newborn lambs, suggesting that this approach may 
be efficacious for neonate immunization (Van Drunen 
Littel-van den Hurk et al., 1999). 
Mucosal delivery of gB-based plasmid DNA vaccines 
has also shown promising results. Delivery of plasmid- 
based BHV-1 gB DNA vaccine in the female vulvomu- 
cosal epithelium induced gB-specific antibodies and 
cellular immune responses. Furthermore, vaccinated 
animals have significantly reduced genital lesions upon . 
genital challenge (Huang et al., 2005). Recent studies 
using a combined g R g D  DNA vaccine in mice indicated 
that mice immunized with the combined vaccine contain- 
ing the secreted forms of the respective glycoproteins 
developed higher titers of anti-BHV-1 neutralizing anti- 
bodies and increased cellular immune response com- 
pared to single plasmid injected groups (Caselli et al., 
2005). 
Use of BHV-1 as a vaccine vector 
BHV-1-based vectors have significant advantages relative 
to other potential virus vectors for immunization of cattle 
against economically important viral and bacterial 
diseases, including those that initiate BRDC. Cattle are 
routinely immunized against BHV-I and, therefore, the 
use of BHV-1 as a vector would not pose a new risk to 
cattle or humans. Gene-deleted BHV-1 strains could be 
used to express other bacterial and viral gene coding 
sequences. BHV-1 expressing the BVD (bovine diarrhea 
<irus) gP53 (E2) protein has been constructed (Kweon 
et al., 1999; Wang et al., 2003a). While the protective 
efficacy of the BHV-1 vectored vaccine against BVD 
challenge has not yet been reported, BHV-1 expressing 
the E2 protein induced BVD gP53-specifc neutralizing 
antibody in vaccinated calves (Kweon et al., 1999). BVD is 
well known to be immunosuppressive and, like many 
RNA viruses, can readily mutate (Peterhans et al., 2006). 
Such complications from modified live BVD vaccines 
could be avoided by using BHV-1 as live attenuated 
vector to deliver BVD-specific protein(s). Similarly, BHV- 
1-expressing bacterial proteins could be used to immu- 
nize against bacterial diseases that affect dairy and beef 
cattle. These may include Mannheimia hemolytica protec- 
tive antigens, which are a significant cause of pneumonia 
that occurs as a result of shipping fever. Similarly, 
Mycobacteriz~m avit~m subspecies paratuberctllosis 
(MAP) is a slow growing bacterium with zoonotic 
potential (Grant, 2005). Development of an effective 
vaccine is hindered due to its extremely slow growth and 
difficulties in protective bacterial antigen purification. 
Several mycobacterial proteins trigger cellular immune 
responses (Rossels et al., 2006), which are important for 
protective immunity against MAP. BHV-1-expressing MAP 
proteins would certainly have a potential as a vaccine 
against MAP and BHV-1. Although BHV-1 can be used as 
a potential vector for delivering foreign antigens to calves, 
C. Jones and S. Chowdhury 
a thorough understanding of the  immune-suppressive 
nature of BHV-1 a n d  the  latency-reactivation cycle is 
essential. 
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